Literature DB >> 33416966

Sacral neuromodulation: troubleshooting needle placement.

Whitney K Hendrickson1, Cindy L Amundsen2.   

Abstract

INTRODUCTION AND HYPOTHESIS: The objective was to develop an instructional video that utilizes fluoroscopic images and anatomical landmarks to increase the surgeon's ability to troubleshoot optimal placement of the foramen needle and lead during a stage I sacral neuromodulation (SNM) procedure.
METHODS: Eight different examples of suboptimal foramen needle placement with subsequent corrections during a SNM procedure were performed and recorded on a fresh female cadaver.
RESULTS: Fluoroscopic images were obtained during the procedure, and illustrations of the posterior aspect of the sacrum highlighting the S3 foramina and nerve are shown for anatomical comparison.
CONCLUSIONS: This video demonstrates how to efficiently identify and correct suboptimal foramen needle placement in order to obtain optimal lead placement during an SNM procedure. Understanding the relationship between the bony landmarks on fluoroscopy and the S3 nerve and foramen are important in order to understand how to correct a suboptimal foramen needle and thus achieve optimal lead placement.

Keywords:  Fecal incontinence; Optimal lead placement; Overactive bladder; Sacral neuromodulation; Sacral neurostimulation; Urgency incontinence; Urinary retention

Year:  2021        PMID: 33416966     DOI: 10.1007/s00192-020-04614-9

Source DB:  PubMed          Journal:  Int Urogynecol J        ISSN: 0937-3462            Impact factor:   2.894


  8 in total

1.  Modified techniques of S3 foramen localization and lead implantation in S3 neuromodulation.

Authors:  T C Chai; G J Mamo
Journal:  Urology       Date:  2001-11       Impact factor: 2.649

2.  Can sensory and/or motor reactions during percutaneous nerve evaluation predict outcome of sacral nerve modulation?

Authors:  B Govaert; J Melenhorst; W G van Gemert; C G Baeten
Journal:  Dis Colon Rectum       Date:  2009-08       Impact factor: 4.585

3.  Five-Year Followup Results of a Prospective, Multicenter Study of Patients with Overactive Bladder Treated with Sacral Neuromodulation.

Authors:  Steven Siegel; Karen Noblett; Jeffrey Mangel; Jason Bennett; Tomas L Griebling; Suzette E Sutherland; Erin T Bird; Craig Comiter; Daniel Culkin; Samuel Zylstra; Fangyu Kan; Kellie Chase Berg
Journal:  J Urol       Date:  2017-07-11       Impact factor: 7.450

4.  Motor Response Matters: Optimizing Lead Placement Improves Sacral Neuromodulation Outcomes.

Authors:  Javier Pizarro-Berdichevsky; Bradley C Gill; Marisa Clifton; Henry T Okafor; Anna E Faris; Sandip P Vasavada; Howard B Goldman
Journal:  J Urol       Date:  2017-11-14       Impact factor: 7.450

5.  International Continence Society best practice statement for use of sacral neuromodulation.

Authors:  Howard B Goldman; Jessica C Lloyd; Karen L Noblett; Marcus P Carey; Juan Carlos Castaño Botero; Jerzy B Gajewski; Paul A Lehur; Magdy M Hassouna; Klaus E Matzel; Ian M Paquette; Stefan de Wachter; Michael J Ehlert; Emmanuel Chartier-Kastler; Steven W Siegel
Journal:  Neurourol Urodyn       Date:  2018-04-11       Impact factor: 2.696

6.  Detailed analysis of adverse events and surgical interventions in a large prospective trial of sacral neuromodulation therapy for overactive bladder patients.

Authors:  Karen Noblett; Kevin Benson; Karl Kreder
Journal:  Neurourol Urodyn       Date:  2016-08-04       Impact factor: 2.696

7.  Two-Year Outcomes of Sacral Neuromodulation Versus OnabotulinumtoxinA for Refractory Urgency Urinary Incontinence: A Randomized Trial.

Authors:  Cindy L Amundsen; Yuko M Komesu; Christopher Chermansky; W Thomas Gregory; Deborah L Myers; Emily F Honeycutt; Sandip P Vasavada; John N Nguyen; Tracey S Wilson; Heidi S Harvie; Dennis Wallace
Journal:  Eur Urol       Date:  2018-02-24       Impact factor: 20.096

8.  Long-term durability of sacral nerve stimulation therapy for chronic fecal incontinence.

Authors:  Tracy Hull; Chad Giese; Steven D Wexner; Anders Mellgren; Ghislain Devroede; Robert D Madoff; Katherine Stromberg; John A Coller
Journal:  Dis Colon Rectum       Date:  2013-02       Impact factor: 4.585

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.